7 completed, 2 recruiting, 2 unknown, 1 not yet recruiting. 12 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Completed 7, Recruiting 2, Unknown 2, Not yet recruiting 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Lung Transplantation: new trials by email Literature Review of Lung Transplantation trials Research Report on Lung Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Low-Frequency rTMS for In-Hospital Sleep Disturbance After Lung Transplantation Active Low-Frequency Repetitive Transcranial Magnetic Stimulation, Sham Repetitive Transcranial Magnetic Stimulation - Sleep Wake Disorders, Lung Transplantation | Phase 2 | Not yet recruiting | The First Affiliated Hospital of Guangzhou Medical University | 152 | 2026-08-31 | 2026-09-01 |
| This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction Maraviroc, Placebo - Primary Graft Dysfunction, Lung Transplantation | Phase 2 | Recruiting | University of California, San Francisco | 120 | 2025-12-07 | 2026-01-20 |
| LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome. LAM-001, Placebo - Bronchiolitis Obliterans Syndrome, Chronic Lung Allograft Dysfunction | Phase 2 | Recruiting | Steven Hays, MD | 30 | 2023-08-17 | 2026-05-18 |
| Naloxone for Optimizing Hypoxemia Of Lung Donors Naloxone, Normal saline - Brain Death, Organ Donors | Phase 2 / Phase 3 | Completed | Washington University School of Medicine | 199 | 2015-09-01 | 2020-07-31 |
| Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients Alpha -1 Antitrypsin, Alpha-1 Antitrypsin, AAT - Lung Transplantation, Bronchiolitis Obliterable Syndrome | Phase 2 | Unknown | Rabin Medical Center | 40 | 2011-09-01 | 2011-07-14 |
| Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf® Advagraf, Prograf - Heart Transplantation, Lung Transplantation | Phase 2 | Completed | Astellas Pharma Inc | 17 | 2011-07-01 | 2015-06-16 |
| Patient Education After Lung Transplantation Via Tablet Computers Versus Conventional Education Patient education - Lung Transplantation | Phase 2 | Completed | Hannover Medical School | 64 | 2011-07-01 | 2013-06-06 |
| Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf® Tacrolimus, Tacrolimus prolonged release - Intestine Transplantation, Kidney Transplantation | Phase 2 | Completed | Astellas Pharma Europe Ltd. | 81 | 2011-05-25 | 2026-10-19 |
| Intravenous Immunoglobulin (IVIG) in Lung Transplantation IVIG, Placebo - Hypogammaglobulinemia, Lung Transplantation | Phase 2 | Completed | Columbia University | 11 | 2005-06-01 | 2019-03-05 |
| Repertaxin in Prevention of Primary Graft Dysfunction After Lung Transplantation Repertaxin, Placebo - Ischemia-Reperfusion Injury, Lung Transplantation | Phase 2 | Completed | Dompé Farmaceutici S.p.A | 114 | 2005-05-01 | 2024-12-11 |
| Safety and Efficacy Study of Nitric Oxide in Patients Going Through Lung Transplantation Nitric oxide - Lung Transplantation | Phase 2 | Completed | Mallinckrodt | 49 | 2005-04-01 | 2016-10-19 |
| The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study Surfactant (calfactant) - Lung Transplantation, Primary Graft Dysfunction | Phase 2 / Phase 3 | Unknown | Rabin Medical Center | 42 | 2005-01-01 | 2007-07-25 |
Primary Graft Dysfunction (2) · Acute Lung Injury (1) · Agammaglobulinemia (1) · Brain Death (1) · Bronchiolitis Obliterans Syndrome (1) · Reperfusion Injury (1) · Sleep Wake Disorders (1)
Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (4) · Cardiovascular Diseases (3) · Postoperative Complications (3) · Vascular Diseases (3) · Immune System Diseases (2) · Lung Diseases (2) · Nervous System Diseases (2) · Neurologic Manifestations (2) · Reperfusion Injury (2) · Respiratory Tract Diseases (2) · Blood Protein Disorders (1) · Brain Diseases (1) · Bronchial Diseases (1) · Bronchiolitis (1)
Tacrolimus (2) · Immunoglobulins, Intravenous (1) · Maraviroc (1) · Naloxone (1) · Nitric Oxide (1) · Patient Education as Topic (1) · Saline Solution (1) · Sodium Chloride (1) · Surface-Active Agents (1) · alpha 1-Antitrypsin (1) · calfactant (1) · gamma-Globulins (1) · reparixin (1)
Rabin Medical Center (2) · Astellas Pharma Europe Ltd. (1) · Astellas Pharma Inc (1) · Columbia University (1) · Dompé Farmaceutici S.p.A (1) · Hannover Medical School (1) · Mallinckrodt (1) · Steven Hays, MD (1) · The First Affiliated Hospital of Guangzhou Medical University (1) · University of California, San Francisco (1) · Washington University School of Medicine (1)
United States (5) · Belgium (2) · France (2) · Germany (2) · Italy (2) · United Kingdom (2) · Austria (1) · Canada (1) · Czechia (1) · Israel (1) · Poland (1) · Spain (1) · Taiwan (1)
Daniel Calabrese, MD (1) · Jens T Gottlieb, MD (1) · MordechaI R Kramer, Prof (1) · Mordechai R Kramer, M.D (1) · Rajat Dhar, MD (1) · Roberto Novellini, MD (1) · Rosario Vicente, MD (1) · Selim M Arcasoy, M.D. (1) · Steven Hays, MD (1)